Wedbush Securities Sees Insulet Corporation Strengthen Bench by Hiring Experienced CFO

In a report published Tuesday, Wedbush Securities analyst Tao Levy reiterated an Outperform rating and $34.00 price target on

. In the report, Wedbush Securities noted, "[Yesterday], after the market close, PODD announced the appointment of Michael Levitz as its new CFO, which continues to reflect the CEO's intention to assemble a highly experienced and accomplished management team, many of whom he previously worked with. Mr. Levitz was CFO of Analogic (ALOG, not rated), a manufacturer of technology components for the medical imaging industry, and will replace Allison Dorval, who announced her resignation today. Mr. Levitz had previously worked with Insulet's CEO, Patrick Sullivan, at Cytyc (after its merger with Hologic in 2007), serving as the company's VP and Corporate Controller." Insulet Corporation closed on Monday at $34.28.